1 week Ago By ABMN Staff
Phreesia ( NYSE:PHR – Get Free Report ) had its target price lifted by equities research analysts at Robert W. Baird from $31.00 to $34.
00 in a note issued to investors on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Robert W.
Baird’s target price indicates a potential upside of 44.37% from the stock’s current price. A number of other research analysts have also recently commented on PHR.
Canaccord Genuity Group reissued a “buy” rating and set a $34.00 target price on shares of Phreesia in a research report on Thursday. DA Davidson reiterated a “buy” rating and issued a $32.
00 price objective on shares of Phreesia in a report on Thursday. JMP Securities restated a “market outperform” rating and set a $30.00 target price on shares of Phreesia in a research note on Thursday.
Truist Financial reiterated a “buy” rating and issued a $29.00 price target on shares of Phreesia in a research note on Monday, July 1st. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $23.
00 price objective on shares of Phreesia in a research note on Thursday. One investment analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.
com, the company has a consensus rating of “Moderate Buy” and an average price target of $30.42. Get Our Latest Analysis on Phreesia Phreesia Stock Performance Insider Transactions at Phreesia In related news, CEO Chaim Indig sold 2,644 shares of the company’s stock in a transaction that occurred on Tuesday, July 16th.
The stock was sold at an average price of $23.74, for a total transaction of $62,768.56.
Following the sale, the chief executive officer now directly owns 1,219,361 shares of the company’s stock, valued at approximately $28,947,630.14. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink .
In other Phreesia news, SVP David Linetsky sold 1,820 shares of Phreesia stock in a transaction that occurred on Tuesday, July 16th. The stock was sold at an average price of $23.74, for a total value of $43,206.
80. Following the completion of the transaction, the senior vice president now directly owns 202,218 shares in the company, valued at $4,800,655.32.
The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink . Also, CEO Chaim Indig sold 2,644 shares of the stock in a transaction that occurred on Tuesday, July 16th. The stock was sold at an average price of $23.
74, for a total value of $62,768.56. Following the sale, the chief executive officer now owns 1,219,361 shares in the company, valued at $28,947,630.
14. The disclosure for this sale can be found here . In the last quarter, insiders sold 29,337 shares of company stock worth $736,750.
5.80% of the stock is currently owned by corporate insiders. Institutional Inflows and Outflows A number of institutional investors have recently added to or reduced their stakes in PHR.
Ensign Peak Advisors Inc lifted its stake in Phreesia by 3.2% in the second quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock valued at $477,000 after buying an additional 700 shares during the last quarter.
Conestoga Capital Advisors LLC increased its holdings in shares of Phreesia by 1.0% in the 1st quarter. Conestoga Capital Advisors LLC now owns 78,085 shares of the company’s stock worth $1,869,000 after acquiring an additional 750 shares during the period.
ProShare Advisors LLC lifted its position in Phreesia by 8.6% in the 1st quarter. ProShare Advisors LLC now owns 9,522 shares of the company’s stock valued at $228,000 after purchasing an additional 751 shares during the last quarter.
Rhumbline Advisers boosted its stake in Phreesia by 1.0% during the 2nd quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock valued at $1,741,000 after purchasing an additional 853 shares during the period.
Finally, Swiss National Bank grew its position in Phreesia by 1.0% in the 1st quarter. Swiss National Bank now owns 104,300 shares of the company’s stock worth $2,496,000 after purchasing an additional 1,000 shares during the last quarter.
92.10% of the stock is currently owned by institutional investors. Phreesia Company Profile ( Get Free Report ) Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.
The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. See Also Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter .
.
